Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test [Yahoo! Finance]
Laboratory Corporation of America Holdings (LH)
Last laboratory corporation of america holdings earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
Labcorp's pTau217 test is now available for physicians and use in clinical trials and research by global biopharmaceutical partners. With the addition of pTau217 as a stand-alone test, Labcorp's portfolio of Alzheimer's tests has advanced significantly, enhancing its current range of blood-based biomarker testing. More on the News Alzheimer's disease, the most common type of dementia, is a major health concern worldwide. Alzheimer's disease affects an estimated 6.7 million Americans, with the number expected to more than quadruple to 13.8 million by 2060. The pTau217 marker has been utilized in Alzheimer's medication studies to follow individuals receiving anti-amyloid therapy. The pTau217 test is a pivotal blood biomarker intended to aid in the diagnosis of Alzheimer's disease and the subsequent monitoring of patients undergoing treatment with new Alzheimer's disease therapies. With this test, Labcorp has expanded its range of Alzheimer's tests. The other tests in the portf
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Laboratory Corporation of America Holdings news events
Weekly update
A roundup of the hottest topics
LH
News
- Laboratory Co. of America Holdings (NYSE: LH) had its price target lowered by analysts at Truist Financial Co. from $270.00 to $255.00. They now have a "buy" rating on the stock.MarketBeat
- Laboratory Co. of America Holdings (NYSE: LH) had its price target lowered by analysts at Barclays PLC from $234.00 to $213.00. They now have an "equal weight" rating on the stock.MarketBeat
- Laboratory Co. of America Holdings (NYSE: LH) had its price target lowered by analysts at Robert W. Baird from $255.00 to $244.00. They now have an "outperform" rating on the stock.MarketBeat
- Laboratory Corporation of America Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
- Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View [Yahoo! Finance]Yahoo! Finance
LH
Earnings
- 4/25/24 - Beat
LH
Sec Filings
- 4/25/24 - Form 8-K
- 4/17/24 - Form 4
- 4/11/24 - Form 8-K
- LH's page on the SEC website